AgomAb Therapeutics NV Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| EQT FUND MANAGEMENT S.A R.L. | 05/14/2026 | 5.14 M | $53.94 M | 100.00% | 14.19% |
| SANOFI | 05/07/2026 | 2.78 M | $29.19 M | 100.00% | 7.68% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2026 | 2.47 M | $25.86 M | 100.00% | 6.80% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/15/2026 | 2.05 M | $21.54 M | 100.00% | 5.67% |
| FEDERATED HERMES, INC. | 05/11/2026 | 1.62 M | $16.97 M | 100.00% | 4.47% |
| CASDIN CAPITAL, LLC | 05/15/2026 | 1.55 M | $16.26 M | 100.00% | 4.28% |
| ANDERA PARTNERS | 05/11/2026 | 1.54 M | $16.14 M | 100.00% | 4.25% |
| FMR LLC | 05/15/2026 | 1.46 M | $15.30 M | 100.00% | 4.03% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.20 M | $12.85 M | 100.00% | 3.31% |
| ABRDN PLC | 04/29/2026 | 707.66 K | $7.42 M | 100.00% | 1.95% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 600.00 K | $6.29 M | 100.00% | 1.66% |
| SAMSARA BIOCAPITAL, LLC | 05/15/2026 | 600.00 K | $6.29 M | 100.00% | 1.66% |
| SIREN, L.L.C. | 05/14/2026 | 411.25 K | $4.31 M | 100.00% | 1.13% |
| LMR PARTNERS LLP | 05/15/2026 | 300.00 K | $3.15 M | 100.00% | 0.83% |
| SEVEN GRAND MANAGERS, LLC | 05/06/2026 | 200.00 K | $2.10 M | 100.00% | 0.55% |
| REDMILE GROUP, LLC | 05/15/2026 | 156.25 K | $1.64 M | 100.00% | 0.43% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 95.23 K | $998.99 K | 100.00% | 0.26% |
| PFIZER INC | 05/12/2026 | 75.00 K | $813.75 K | 100.00% | 0.21% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 75.00 K | $786.75 K | 100.00% | 0.21% |
| LAURION CAPITAL MANAGEMENT LP | 05/14/2026 | 50.00 K | $524.50 K | 100.00% | 0.14% |
| BELLEVUE GROUP AG | 05/15/2026 | 50.00 K | $524.50 K | 100.00% | 0.14% |
| SECTORAL ASSET MANAGEMENT INC | 05/15/2026 | 43.50 K | $477.30 K | 100.00% | 0.12% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 35.74 K | $374.90 K | 100.00% | 0.10% |
| CITADEL ADVISORS LLC | 05/15/2026 | 35.00 K | $367.15 K | 100.00% | 0.10% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 05/15/2026 | 35.00 K | $367.15 K | 100.00% | 0.10% |
| HRT FINANCIAL LP | 05/14/2026 | 23.73 K | $248.00 K | 100.00% | 0.07% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 15.33 K | $160.77 K | 100.00% | 0.04% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 14.24 K | $149.39 K | 100.00% | 0.04% |
| JANE STREET GROUP, LLC | 05/12/2026 | 12.79 K | $134.21 K | 100.00% | 0.04% |
| UBS GROUP AG | 05/05/2026 | 6.44 K | $67.52 K | 100.00% | 0.02% |
| MORGAN STANLEY | 05/15/2026 | 3.03 K | $31.73 K | 100.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 2 | $21 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AgomAb Therapeutics NV institutional Ownership - FAQ's
During the previous two years, 32 institutional investors and hedge funds held shares of AgomAb Therapeutics NV. The most heavily invested institutionals were:
EQT Fund Management S.a r.l.: 5.14 M
Sanofi: 2.78 M
Cormorant Asset Management, LP: 2.47 M
TCG Crossover Management, LLC: 2.05 M
FEDERATED HERMES, INC.: 1.62 M
Casdin Capital, LLC: 1.55 M
64.45% of AgomAb Therapeutics NV stock is owned by institutional investors.
Institutional investors have bought a total of 23.35 M shares in the last 24 months. This purchase volume represents approximately $337.00 M in transactions.